AMAG PHARMACEUTICALS INC's ticker is and the CUSIP is 00163UAD8. A total of 30 filers reported holding AMAG PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $844,000 | -48.7% | 1,000,000 | -50.0% | 0.05% | -55.7% |
Q3 2019 | $1,645,000 | -40.0% | 2,000,000 | -33.3% | 0.11% | -42.4% |
Q4 2018 | $2,742,000 | +12.8% | 3,000,000 | +27.4% | 0.18% | +61.4% |
Q2 2018 | $2,431,000 | -52.9% | 2,355,000 | -52.9% | 0.11% | -55.6% |
Q1 2018 | $5,165,000 | – | 5,000,000 | – | 0.26% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Context Capital Management, LLC | 8,800,000 | $9,006,000 | 7.74% |
STEELHEAD PARTNERS LLC | 49,265,000 | $50,805,000 | 4.45% |
TENOR CAPITAL MANAGEMENT Co., L.P. | 38,025,000 | $39,317,000 | 2.35% |
CAMDEN ASSET MANAGEMENT L P /CA | 25,875,000 | $26,415,000 | 0.87% |
Opera Trading Capital | 4,500,000 | $4,620,000 | 0.74% |
Telemetry Investments, L.L.C. | 1,500,000 | $1,531,000 | 0.58% |
SSI INVESTMENT MANAGEMENT LLC | 5,500,000 | $5,615,000 | 0.46% |
AQR Arbitrage LLC | 32,975,000 | $33,746,000 | 0.42% |
WOLVERINE ASSET MANAGEMENT LLC | 31,050,000 | $32,023,000 | 0.41% |
City Financial Investment Co Ltd | 7,500,000 | $7,862,000 | 0.40% |